Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
PLoS One. 2013 Oct 7;8(10):e75358. doi: 10.1371/journal.pone.0075358. eCollection 2013.
OptZyme is a new computational procedure for designing improved enzymatic activity (i.e., kcat or kcat/KM) with a novel substrate. The key concept is to use transition state analogue compounds, which are known for many reactions, as proxies for the typically unknown transition state structures. Mutations that minimize the interaction energy of the enzyme with its transition state analogue, rather than with its substrate, are identified that lower the transition state formation energy barrier. Using Escherichia coli β-glucuronidase as a benchmark system, we confirm that KM correlates (R(2) = 0.960) with the computed interaction energy between the enzyme and the para-nitrophenyl- β, D-glucuronide substrate, kcat/KM correlates (R(2) = 0.864) with the interaction energy of the transition state analogue, 1,5-glucarolactone, and kcat correlates (R(2) = 0.854) with a weighted combination of interaction energies with the substrate and transition state analogue. OptZyme is subsequently used to identify mutants with improved KM, kcat, and kcat/KM for a new substrate, para-nitrophenyl- β, D-galactoside. Differences between the three libraries reveal structural differences that underpin improving KM, kcat, or kcat/KM. Mutants predicted to enhance the activity for para-nitrophenyl- β, D-galactoside directly or indirectly create hydrogen bonds with the altered sugar ring conformation or its substituents, namely H162S, L361G, W549R, and N550S.
OptZyme 是一种新的计算程序,用于设计具有新型底物的改良酶活性(即 kcat 或 kcat/KM)。关键概念是使用过渡态类似物化合物,这些化合物在许多反应中是已知的,作为通常未知的过渡态结构的代理。确定的突变最小化了酶与其过渡态类似物的相互作用能,而不是与其底物的相互作用能,从而降低了过渡态形成能垒。使用大肠杆菌β-葡糖苷酸酶作为基准系统,我们证实 KM 与酶与对硝基苯-β-D-葡糖苷酸底物之间的计算相互作用能相关(R²=0.960),kcat/KM 与过渡态类似物 1,5-葡糖内酯的相互作用能相关(R²=0.864),kcat 与与底物和过渡态类似物的相互作用能的加权组合相关(R²=0.854)。随后,OptZyme 用于识别具有改良 KM、kcat 和 kcat/KM 的新底物对硝基苯-β-D-半乳糖苷的突变体。三个文库之间的差异揭示了改善 KM、kcat 或 kcat/KM 的结构差异。预测直接或间接通过与改变的糖环构象或其取代基形成氢键来增强对硝基苯-β-D-半乳糖苷活性的突变体,即 H162S、L361G、W549R 和 N550S。